Videos

The Senate Judiciary Committee held a hearing on the role of intellectual property in the pricing of prescription drugs. Witnesses included pharmaceutical executives, academic scholars, and …

Witnesses testified on drug company “pay-for-delay” deals, a ploy by to keep generic alternatives off the market. The Supreme Court recently ruled that these deals are subject to anti-trust …